Visit coronavirus.gov for the latest Coronavirus Disease (COVID-19) updates.

You are here

Evidence-Based Resource Summary

Strength of Evidence: 
4 out of 4
4 out of 4
Year Published: 
2016

Aspirin to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication in Adults Ages 50 to 59 Years

Description of Resource: 
The U.S. Preventive Services Task Force (USPSTF) recommends low-dose aspirin use for the primary prevention of colorectal cancer in adults ages 50–59 years who are not at increased risk for bleeding, have a life expectancy of at least 10 years, and are willing to take low-dose aspirin daily for at least 10 years. This is a B recommendation, which means the USPSTF recommends the service. There is high certainty that the net benefit is moderate or there is moderate certainty that the net benefit is moderate to substantial.

Evidence-Based Resource Details

help Learn more about EBR criteria
Developed By: 
U.S. Preventive Services Task Force
Developer Type: 
Federal Government
Healthy People 2020 Topic Area(s): 
Cancer
Healthy People 2020 Objectives: 
Resource Type: 
Systematic Review
Citation: 
Final Recommendation Statement: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication. U.S. Preventive Services Task Force [Internet]. 2016 Nov [cited 2017 Aug 7]. Available from: https://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/aspirin-to-prevent-cardiovascular-disease-and-cancer